UA81629C2 - Применение композиции и способ лечения инфекционных заболеваний крупного рогатого скота и свиней - Google Patents

Применение композиции и способ лечения инфекционных заболеваний крупного рогатого скота и свиней

Info

Publication number
UA81629C2
UA81629C2 UA20041210427A UA20041210427A UA81629C2 UA 81629 C2 UA81629 C2 UA 81629C2 UA 20041210427 A UA20041210427 A UA 20041210427A UA 20041210427 A UA20041210427 A UA 20041210427A UA 81629 C2 UA81629 C2 UA 81629C2
Authority
UA
Ukraine
Prior art keywords
swine
cattle
compositions
treating infection
disclosed
Prior art date
Application number
UA20041210427A
Other languages
English (en)
Ukrainian (uk)
Inventor
Рауль Э. Кохан
Кенвал Дж. Варма
Абу Хук
Кейт А. Фрихауф
Original Assignee
Schering Plough Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Plough Ltd filed Critical Schering Plough Ltd
Publication of UA81629C2 publication Critical patent/UA81629C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Изобретение касается рецептур, которые объединяют нестероидное противовоспалительное лечебное средство (NSAID), такое как флуниксин, с фторированным производным антибиотика хлорамфеникола или тиамфеникола, таким как флорфеникол. Также изобретение касается способа использования таких рецептур при лечении и предупреждении инфекционных заболеваний коров и свиней, включая респираторное заболевание коров и респираторное заболевание свиней.
UA20041210427A 2002-05-20 2003-05-19 Применение композиции и способ лечения инфекционных заболеваний крупного рогатого скота и свиней UA81629C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38201502P 2002-05-20 2002-05-20
PCT/IB2003/002152 WO2003097054A1 (en) 2002-05-20 2003-05-19 Compositions and method for treating infection in cattle and swine

Publications (1)

Publication Number Publication Date
UA81629C2 true UA81629C2 (ru) 2008-01-25

Family

ID=29550174

Family Applications (1)

Application Number Title Priority Date Filing Date
UA20041210427A UA81629C2 (ru) 2002-05-20 2003-05-19 Применение композиции и способ лечения инфекционных заболеваний крупного рогатого скота и свиней

Country Status (29)

Country Link
US (3) US6790867B2 (ru)
EP (1) EP1505975B1 (ru)
JP (2) JP4772324B2 (ru)
KR (1) KR101102176B1 (ru)
CN (1) CN100563655C (ru)
AR (1) AR039826A1 (ru)
AU (1) AU2003228042B2 (ru)
BR (1) BRPI0311126B1 (ru)
CA (1) CA2485491C (ru)
CY (1) CY1107176T1 (ru)
DE (1) DE60317662T2 (ru)
DK (1) DK1505975T3 (ru)
EC (1) ECSP045442A (ru)
ES (1) ES2295583T3 (ru)
HK (1) HK1072547A1 (ru)
IL (2) IL165252A0 (ru)
MX (1) MXPA04011516A (ru)
MY (1) MY135791A (ru)
NO (1) NO20045547L (ru)
NZ (1) NZ536476A (ru)
PE (1) PE20040041A1 (ru)
PL (1) PL213975B1 (ru)
PT (1) PT1505975E (ru)
RU (2) RU2330662C2 (ru)
SI (1) SI1505975T1 (ru)
TW (1) TWI355266B (ru)
UA (1) UA81629C2 (ru)
WO (1) WO2003097054A1 (ru)
ZA (1) ZA200409296B (ru)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11337894B2 (en) 2018-06-15 2022-05-24 James T. Doubet Syringe adapter for animal medication
US11097058B2 (en) 2018-06-15 2021-08-24 James T. Doubet Syringe adapter for medication
US11090444B2 (en) 2018-06-15 2021-08-17 James T. Doubet Syringe adapter for medication
US10709850B2 (en) 2018-06-15 2020-07-14 James T. Doubet Syringe adapter for medication
US6432203B1 (en) * 1997-03-17 2002-08-13 Applied Komatsu Technology, Inc. Heated and cooled vacuum chamber shield
US20070003508A1 (en) 2005-07-01 2007-01-04 Wooley Richard E Methods and compositions for promoting wound healing
US20040208842A1 (en) * 2001-09-18 2004-10-21 Ritchie Branson W. Antimicrobial cleansing compositions and methods of use
US6787568B1 (en) * 2000-11-27 2004-09-07 Phoenix Scientific, Inc. Antibiotic/analgesic formulation and a method of making this formulation
WO2003034988A2 (en) * 2001-10-19 2003-05-01 Idexx Laboratories, Inc. Injectable compositions for the controlled delivery of pharmacologically active compound
US6790867B2 (en) * 2002-05-20 2004-09-14 Schering-Plough Animal Health Corporation Compositions and method for treating infection in cattle and swine
UA82359C2 (ru) * 2003-04-03 2008-04-10 Schering Plough Ltd Композиция (варианты) и способ лечения микробных и паразитарных инфекций у крупного рогатого скота и других животных
TW200505425A (en) * 2003-05-29 2005-02-16 Schering Plough Ltd Compositions and method for treating infection in cattle and swine
US7439268B2 (en) * 2003-07-18 2008-10-21 Idexx Laboratories Compositions containing prodrugs of florfenicol and methods of use
WO2005044254A1 (en) * 2003-10-29 2005-05-19 Idexx Laboratories, Inc. Salts of pharmacologically active compounds
KR100548948B1 (ko) * 2003-11-24 2006-02-02 주식회사 한동 플로르페니콜의 약제학적 조성물
WO2005091967A2 (en) * 2004-03-03 2005-10-06 University Of Georgia Research Foundation, Inc. Methods and compositions for ophthalmic treatment of fungal and bacterial infections
WO2007058639A2 (en) * 2004-09-02 2007-05-24 Idexx Laboratories Inc. Antibacterial agents
ATE411046T1 (de) * 2004-12-21 2008-10-15 Intervet Int Bv Injizierbare veterinärmedizinische zusammensetzung enthaltend florfenicol
US8119667B2 (en) * 2005-12-29 2012-02-21 Schering-Plough Animal Health Corporation Carbonates of fenicol antibiotics
US7518017B2 (en) 2006-02-17 2009-04-14 Idexx Laboratories Fenicol compounds and methods synthesizing 2-trifluoroacetamido-3-substituted propiophenone compounds
MX2009006282A (es) * 2006-12-13 2009-06-23 Schering Plough Ltd Profarmacos solubles en agua de florfenicol y sus analogos.
WO2008076256A1 (en) * 2006-12-13 2008-06-26 Schering-Plough Ltd. Water-soluble prodrugs of chloramphenicol, thiamphenicol, and analogs thereof
KR20090090387A (ko) * 2006-12-19 2009-08-25 쉐링-프라우 리미티드 음료수 시스템 내에 추가하기 위한 플로르페니콜의 비등성 제형
PE20081406A1 (es) * 2006-12-20 2008-10-17 Schering Plough Ltd Composiciones farmaceuticas de flunixina
RU2009143731A (ru) * 2007-04-27 2011-06-10 Шеринг-Плоу Лтд. (CH) Соединения и способы улучшения растворимости флорфеникола и структурно родственных антибиотиков с помощью циклодекстринов
US7550625B2 (en) 2007-10-19 2009-06-23 Idexx Laboratories Esters of florfenicol
PE20091171A1 (es) * 2007-12-14 2009-08-03 Schering Plough Ltd Proceso para recuperar florfenicol y analogos de florfenicol
EP2229149B1 (en) * 2007-12-14 2012-03-07 Intervet International B.V. Process for recovering flunixin from pharmaceutical compositions
FR2925334A1 (fr) * 2007-12-21 2009-06-26 Ceva Sante Animale Sa Nouvelles compositions antibacteriennes
WO2009143558A1 (en) * 2008-05-26 2009-12-03 Silphion Pty Limited Injectable formulations
CN101461821B (zh) * 2008-07-04 2011-05-18 青岛康地恩药业有限公司 一种用于治疗猪、牛呼吸道疾病的复方口服药物组合物
NZ591235A (en) 2008-07-23 2012-07-27 Ambrx Inc Modified bovine g-csf polypeptides comprising non natural amino acid and their uses treating infections such as mastitis
US8314252B2 (en) * 2008-07-30 2012-11-20 Intervet Inc. Process for preparing oxazoline-protected aminodiol compounds useful as intermediates to florfenicol
BRPI1002021A2 (pt) * 2010-01-21 2012-05-22 Nanocore Biotecnologia S A composições farmacêuticas para tratamento de infecções bacterianas
AR083006A1 (es) 2010-09-23 2013-01-23 Lilly Co Eli Formulaciones para el factor estimulante de colonias de granulocitos (g-csf) bovino y variantes de las mismas
CN102188422B (zh) * 2011-01-11 2013-11-06 广东大华农动物保健品股份有限公司 一种复方氟苯尼考注射液及其制备方法和应用
EA019956B1 (ru) * 2011-02-24 2014-07-30 Закрытое Акционерное Общество "Нита-Фарм" Фармацевтическая композиция для лечения заболеваний бактериальной и микоплазменной этиологии
UA110436C2 (en) * 2012-03-06 2015-12-25 Zoetis Llc Antibacterial phenol compounds
CN104684898A (zh) * 2012-09-26 2015-06-03 佐蒂斯有限责任公司 酰胺醇类抗细菌剂
CN102920701A (zh) * 2012-11-02 2013-02-13 青岛康地恩药业股份有限公司 一种用于治疗猪呼吸道感染疾病的复方氟苯尼考制剂及其制备方法
CN104208062A (zh) * 2013-06-03 2014-12-17 中国农业科学院兰州畜牧与兽药研究所 一种高浓度复方氟苯尼考注射液及其制备方法和应用
CN104095996A (zh) * 2014-08-12 2014-10-15 王忠亮 一种治疗急性脓肿期乳腺炎的药物组合物
CN104188901A (zh) * 2014-08-12 2014-12-10 河南迪冉生物科技有限公司 一种兽用氟苯尼考注射液及其制备方法
CN104370782A (zh) * 2014-11-29 2015-02-25 郑州后羿制药有限公司 一种氟苯尼考的精制方法
RU2655772C1 (ru) * 2016-12-26 2018-05-29 Федеральное государственное бюджетное научное учреждение "Курский научно-исследовательский институт агропромышленного производства" Йодсодержащий состав для лечения мастита у коров
USD890925S1 (en) 2018-06-15 2020-07-21 James T. Doubet Syringe adapter for medication
US20190388625A1 (en) 2018-06-15 2019-12-26 James T. Doubet Syringe adapter for medication
CN108904442B (zh) * 2018-08-09 2021-04-06 山西瑞象生物药业有限公司 一种氟苯尼考溶液剂及其制备方法
JP2021536485A (ja) * 2018-09-06 2021-12-27 イッサム・リサーチ・ディベロップメント・カンパニー・オブ・ザ・ヘブルー・ユニバーシティ・オブ・エルサレム・リミテッド 注射可能な徐放性の抗生物質製剤
CN110208397B (zh) * 2019-05-17 2022-08-19 河北远征药业有限公司 一种同时测定土霉素氟尼辛注射液中两种主药含量的高效液相色谱法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3025325A1 (de) * 1980-07-04 1982-02-04 Merck Patent Gmbh, 6100 Darmstadt Neue 13-thiaprostaglandin-zwischenprodukte, verfahren zu ihrer herstellung und ihre verwendung zur herstellung von 13-thiaprostaglandin-derivaten
US5082863A (en) * 1990-08-29 1992-01-21 Schering Corporation Pharmaceutical composition of florfenicol
US5082653A (en) * 1990-10-31 1992-01-21 Warner-Lambert Company Anti-plaque compositions comprising a combination of morpholinoamino alcohol and antibiotic
US5242910A (en) * 1992-10-13 1993-09-07 The Procter & Gamble Company Sustained release compositions for treating periodontal disease
TR199902748T2 (xx) 1997-05-06 2000-05-22 Norbrook Laboratories Limited Uzun s�re etkili antimikrobik maddelerle ilgili geli�meler
JP2003512290A (ja) * 1997-09-10 2003-04-02 メルク エンド カムパニー インコーポレーテッド 家畜抗菌剤としての８ａ−アザライド
US6423298B2 (en) * 1998-06-18 2002-07-23 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceutical formulations for aerosols with two or more active substances
TR200103271T2 (tr) * 1999-05-14 2002-06-21 The Regents Of The University Of California İnflamasyon aracılığıyla gerçekleşen infeksiyon için anti-inflamatuar tedavi.
US6787568B1 (en) 2000-11-27 2004-09-07 Phoenix Scientific, Inc. Antibiotic/analgesic formulation and a method of making this formulation
US6790867B2 (en) * 2002-05-20 2004-09-14 Schering-Plough Animal Health Corporation Compositions and method for treating infection in cattle and swine
TW200505425A (en) * 2003-05-29 2005-02-16 Schering Plough Ltd Compositions and method for treating infection in cattle and swine

Also Published As

Publication number Publication date
BR0311126A (pt) 2005-03-08
MXPA04011516A (es) 2005-02-14
DE60317662T2 (de) 2008-10-30
US20030220302A1 (en) 2003-11-27
CN100563655C (zh) 2009-12-02
TW200307536A (en) 2003-12-16
JP4772324B2 (ja) 2011-09-14
JP2005526849A (ja) 2005-09-08
TWI355266B (en) 2012-01-01
PL374575A1 (en) 2005-10-31
DE60317662D1 (de) 2008-01-03
CY1107176T1 (el) 2012-10-24
NZ536476A (en) 2008-10-31
EP1505975A1 (en) 2005-02-16
RU2008107582A (ru) 2009-09-10
ECSP045442A (es) 2005-01-03
WO2003097054A1 (en) 2003-11-27
ZA200409296B (en) 2005-07-27
KR20050010818A (ko) 2005-01-28
AU2003228042B2 (en) 2006-09-21
US8044102B2 (en) 2011-10-25
CA2485491C (en) 2012-12-04
IL165252A0 (en) 2005-12-18
ES2295583T3 (es) 2008-04-16
CN1652783A (zh) 2005-08-10
US20050288261A1 (en) 2005-12-29
SI1505975T1 (sl) 2008-06-30
IL165252A (en) 2011-11-30
PT1505975E (pt) 2008-01-31
US20030216447A1 (en) 2003-11-20
RU2004137273A (ru) 2005-07-10
EP1505975B1 (en) 2007-11-21
US6790867B2 (en) 2004-09-14
MY135791A (en) 2008-06-30
RU2330662C2 (ru) 2008-08-10
PL213975B1 (pl) 2013-05-31
JP2006213731A (ja) 2006-08-17
CA2485491A1 (en) 2003-11-27
RU2466726C2 (ru) 2012-11-20
AU2003228042A1 (en) 2003-12-02
BRPI0311126B1 (pt) 2016-11-08
PE20040041A1 (es) 2004-01-24
KR101102176B1 (ko) 2012-01-02
NO20045547L (no) 2004-12-17
HK1072547A1 (en) 2005-09-02
AR039826A1 (es) 2005-03-02
DK1505975T3 (da) 2008-01-14

Similar Documents

Publication Publication Date Title
UA81629C2 (ru) Применение композиции и способ лечения инфекционных заболеваний крупного рогатого скота и свиней
TW200505425A (en) Compositions and method for treating infection in cattle and swine
CY1120977T1 (el) Θεραπεια των ασθενειων αποθηκευσης γλυκογονου τυπου ιι
BRPI0412526A (pt) composto, uso de um composto, composição farmacêutica, formulação em aerossol farmacêutica, e, método para o tratamento de um paciente humano ou animal com uma condição anti-inflamatória e/ou alérgica
LU91928I2 (fr) Ipilimumab et ses dérivés pharmaceutiquement acceptables (YERVOY®)
YU71901A (sh) NOVE VRSTE LEKOVITIH KOMPOZICIJA NA BAZI JEDINJENJA KOJA DELUJU ANTIHOLINERGIJSKI I beta-MIMETIKA
ECSP056074A (es) Composiciones y método para tratar las infecciones microbianas y parasitarias en el ganado y otros animales
NO20060971L (no) Pyridazinderivater og deres anvendelse som terapeutiske midler
BRPI0418251B8 (pt) fosfonatos, monofosfonamidatos, bisfosfonamidatos, e, composição farmacêutica os compreendendo
BR0213040A (pt) Composto, processo para preparar um composto, e, método de tratar doenças
BRPI0411743A (pt) método e composições para tratar doenças relacionadas a amilóides
EA200300776A1 (ru) Производные фенэтаноламина для лечения респираторных заболеваний
BR0313371A (pt) Composto, uso de um composto e método de tratamento de doença
WO2003096990A3 (en) Protein cages for the delivery of medical imaging and therapy
BR0205722A (pt) Formulação de liberação prolongada e método para o tratamento de um paciente que sofre de dor
TW200833367A (en) Pharmaceutical compositions and method for treating inflammation in cattle and other animals
BR0313148A (pt) Formulações de liberação controlada compreendendo lamotrigina
BRPI0415179A (pt) derivados de amida como ligandos de canal de ìon e composições farmacêuticas e métodos de empregar as mesmas
BR0316458A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, método para intensificar a cognição em um paciente saudável, e, uso de um composto
BR9813318A (pt) Processo de tratamento de tumores e degeneração macular em paciente humano ou veterinário, composição farmacêutica para tratamento de tumores e degeneração macular em um paciente humano ou veterinário
BRPI0411176A (pt) combinação farmacêutica consistindo de modafinil e outra droga
CY1109666T1 (el) Μεθοδος θεραπειας διαταραχων ξηροφθαλμιας και ραγοειδιτιδας
BR0315247A (pt) Composição, composição farmacêutica, método de tratamento para uma doença proliferativa celular, e, kit
DK1237562T3 (da) Fremgangsmåde til fremstilling af mikania-ekstrakter, som indeholder mikanolid og dihydromikanolid, og anvendelse i behandlingen af prolifererende sygdomme
WO2004010934A3 (en) Methods for the use of neurotoxin in the treatment of urologic disorders